Across TCGA pan-cancer cohorts, HSFY7P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated HSFY7P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher HSFY7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HSFY7P expression acts as an unfavorable survival marker.

LUAD are the cancer types where HSFY7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.301	0.698	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: HSFY7P tumor-vs-normal RNA expression · all HSFY7P data types